| Product Code: ETC13148153 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 1.1 Billion |
| Forecast Size (2032) | USD 1.7 Billion |
| CAGR | 6.40% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Anticoagulation Monitoring Devices |
| Fastest Growing Segment | Viscoelastic Function Monitoring Devices |
| Leading Companies | Roche, Abbott, Siemens Healthineers, SonoSite, HemoSonics |

The Global Point of Care Coagulation Testing Devices Market was estimated at USD 1.1 Billion in 2025 and is projected to reach USD 1.7 Billion by 2032, growing at a CAGR of 6.40% from 2026 to 2032.
Currently, the Global Point of Care Coagulation Testing Devices Market is undergoing rapid transformation. Key driving forces include the demand for immediate diagnostic feedback and the need for convenient testing solutions in decentralized healthcare settings. The importance of blood coagulation monitoring in managing conditions such as anticoagulant therapy is also influencing significant changes in clinical practices.
This market stands out from adjacent sectors due to its focus on portable devices, enabling healthcare professionals to deliver rapid, accurate testing at the site of care. User-friendly innovations are making these devices more accessible, while also emphasizing individualized patient care, which is essential in an aging population prone to coagulation disorders.
This graph illustrates the annual growth rates of the Global Point of Care Coagulation Testing Devices Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 5.79 | Biosensor technology investments enhance the development of point of care coagulation devices. |
| 2023 | 6.23 | In Europe, market expansion for coagulation testing devices enhances healthcare access. |
| 2024 | 7.61 | Increasing end-user interest drives advancements in point of care coagulation testing devices. |
| 2025 | 5.75 | Hospitals are adopting innovative point of care devices for improved patient outcomes. |
| 2026 | 5.84 | As supply chain dynamics stabilize, the availability of coagulation testing devices improves. |
| 2027 | 7.09 | A rising focus on patient outcomes data emphasizes the need for accurate testing devices. |
| 2028 | 5.54 | New regulatory frameworks streamline the approval of coagulation testing devices for wider use. |
| 2029 | 7.49 | A shift toward telehealth platforms enhances the utilization of coagulation testing technologies. |
| 2030 | 7.03 | Healthcare providers prioritize sustainable practices in deploying point of care testing devices. |
| 2031 | 5.99 | The rising costs of raw materials for coagulation testing devices pressure pricing strategies. |
| 2032 | 5.96 | Diagnostic imaging firms are increasingly entering the point of care coagulation device market. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
Despite its growth potential, the Global Point of Care Coagulation Testing Devices Market faces notable challenges. Regulatory hurdles, specifically related to product approvals and compliance with health standards, can significantly delay market entry. For instance, the average cost of regulatory approval for medical devices can exceed $1 million, creating barriers for smaller companies aiming to innovate within the space. Furthermore, a lack of awareness among healthcare professionals regarding the benefits of these devices can hinder market penetration, as some practitioners still rely on traditional testing methods.
The Global Point of Care Coagulation Testing Devices Market is witnessing distinct technological shifts. One significant trend is the increasing integration of artificial intelligence (AI) in diagnostic devices, leading to improved accuracy in test results and timely interventions. For instance, in 2023, Abbott introduced an AI-driven coagulation analysis system that has reduced test interpretation time by approximately 30%.
Furthermore, there's a strong push towards the development of multi-parameter testing devices that can perform various coagulation tests simultaneously. This approach not only saves time but also enhances workflow efficiency in clinical settings. Companies like Siemens Healthineers are leading this innovation with their comprehensive testing solutions that facilitate rapid clinical decision-making.
The Global Point of Care Coagulation Testing Devices Market presents numerous revenue opportunities in the near future. One key area of growth is in home healthcare, where patient self-testing is becoming increasingly preferred. For instance, companies such as HemoSonics are developing compact devices that allow patients to monitor their coagulation levels at home, aligning with the trend of personalized medicine.
Additionally, as regulatory bodies emphasize quality and efficiency in healthcare delivery, companies that can offer integrated platforms that connect with healthcare IT systems will find considerable demand. The push towards telehealth solutions amid the pandemic has further fueled investments in point-of-care technology, indicating lasting growth potential.
In the Global Point of Care Coagulation Testing Devices Market, Anticoagulation Monitoring Devices lead with an estimated share of about 52% as of 2025. This dominance is due to their critical role in managing anticoagulant therapies in a broad array of clinical scenarios. Meanwhile, the Viscoelastic Function Monitoring Devices segment is projected to experience the fastest growth with a CAGR of 8.2% from 2026 to 2032, driven by increasing applications in surgeries and trauma care, where rapid assessment of coagulation status is crucial.
Hospitals and Clinics currently represent the largest end-user segment in the Global Point of Care Coagulation Testing Devices Market, accounting for roughly 60% share in 2025. This preference is attributed to the high patient turnover and the urgent need for timely coagulation testing in clinical practices. Conversely, the Home Care segment is expected to grow at a faster rate, with a CAGR of 7.5% from 2026 to 2032, reflecting the ongoing shift towards decentralized healthcare and patient self-management initiatives.
North America is anticipated to command the largest share in the Global Point of Care Coagulation Testing Devices Market, holding approximately 43% share in 2025. This is supported by a robust healthcare infrastructure and high investment in medical technology. However, the Asia-Pacific region is projected to be the fastest-growing market, expecting a CAGR of 8.5% from 2026 to 2032, driven by increasing healthcare access and expanding urban populations in emerging economies.
The regulatory environment surrounding the Global Point of Care Coagulation Testing Devices Market is continually evolving, with various government initiatives aimed at enhancing healthcare delivery and ensuring patient safety. These initiatives often include funding schemes, regulatory pathways, and public health programs specifically targeting advancements in medical devices.
The trajectory of the Global Point of Care Coagulation Testing Devices Market indicates a notable shift toward increasing automation and connectivity in healthcare. By 2026, companies like Roche are expected to integrate next-generation connectivity features into their devices, enhancing real-time data sharing with electronic health records. This evolution will likely stimulate early interventions and better patient outcomes while fostering collaborations among healthcare providers, paving the way for a more streamlined point-of-care experience.
Recent advancements in the Global Point of Care Coagulation Testing Devices Market underscore the competitive landscape and growing focus on innovative solutions.
The competitive landscape of the Global Point of Care Coagulation Testing Devices Market is notably fragmented, with several key players establishing their niches through specialized technology and regional expertise.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Roche | Strong in integrated healthcare solutions | Enhancing connectivity in diagnostic devices |
| Abbott | Advanced portable testing technology | Expanding into urgent care markets |
| Siemens Healthineers | Robust manufacturing capabilities | Scaling production to meet market demands |
| SonoSite | Expertise in ultrasound systems | Integrating coagulation testing with ultrasound |
| HemoSonics | Innovative sensor technologies | Developing user-friendly, accurate devices |
As companies continue to innovate and expand their product portfolios, understanding these competitive strengths will be crucial for navigating the dynamics of the market.
Global Point of Care Coagulation Testing Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Point of Care Coagulation Testing Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Global Point of Care Coagulation Testing Devices Market - Industry Life Cycle |
3.4 Global Point of Care Coagulation Testing Devices Market - Porter's Five Forces |
3.5 Global Point of Care Coagulation Testing Devices Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Point of Care Coagulation Testing Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.7 Global Point of Care Coagulation Testing Devices Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Point of Care Coagulation Testing Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Point of Care Coagulation Testing Devices Market Trends |
6 Global Point of Care Coagulation Testing Devices Market, 2022-2032 |
6.1 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Anticoagulation Monitoring Devices, 2022-2032 |
6.1.3 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Platelet Function Monitoring Devices, 2022-2032 |
6.1.4 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Viscoelastic Function Monitoring Devices, 2022-2032 |
6.1.5 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Others, 2022-2032 |
6.2 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Hospitals and Clinics, 2022-2032 |
6.2.3 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Home Care and, 2022-2032 |
6.2.4 Global Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Others, 2022-2032 |
6.3.1 Overview & Analysis |
7 North America Point of Care Coagulation Testing Devices Market, Overview & Analysis |
7.1 North America Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
7.2 North America Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
7.3 North America Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
7.4 North America Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Point of Care Coagulation Testing Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
8.4 Latin America (LATAM) Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Point of Care Coagulation Testing Devices Market, Overview & Analysis |
9.1 Asia Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
9.2 Asia Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
9.2.2 China Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
9.3 Asia Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
9.4 Asia Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Point of Care Coagulation Testing Devices Market, Overview & Analysis |
10.1 Africa Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
10.2 Africa Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
10.3 Africa Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
10.4 Africa Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Point of Care Coagulation Testing Devices Market, Overview & Analysis |
11.1 Europe Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
11.2 Europe Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
11.2.3 France Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
11.3 Europe Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
11.4 Europe Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Point of Care Coagulation Testing Devices Market, Overview & Analysis |
12.1 Middle East Point of Care Coagulation Testing Devices Market Revenues & Volume, 2022-2032 |
12.2 Middle East Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Point of Care Coagulation Testing Devices Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Point of Care Coagulation Testing Devices Market, Revenues & Volume, By Device Type, 2022-2032 |
12.4 Middle East Point of Care Coagulation Testing Devices Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Point of Care Coagulation Testing Devices Market Key Performance Indicators |
14 Global Point of Care Coagulation Testing Devices Market - Export/Import By Countries Assessment |
15 Global Point of Care Coagulation Testing Devices Market - Opportunity Assessment |
15.1 Global Point of Care Coagulation Testing Devices Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Point of Care Coagulation Testing Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
15.3 Global Point of Care Coagulation Testing Devices Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Point of Care Coagulation Testing Devices Market - Competitive Landscape |
16.1 Global Point of Care Coagulation Testing Devices Market Revenue Share, By Companies, 2025 |
16.2 Global Point of Care Coagulation Testing Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here